Skip to main content
Industry News
Breast cancer CDx from Roche approved
7/30/2020

Roche's Ventana HER2 Dual ISH DNA Probe Cocktail test has been approved by the FDA for use as a companion diagnostic for Roche's Herceptin, or trastuzumab.

Full Story: